The role of PI3K/AKT and MAPK signaling pathways in erythropoietin signalization

Z Tóthová, M Šemeláková, Z Solárová, J Tomc… - International Journal of …, 2021 - mdpi.com
Erythropoietin (EPO) is a glycoprotein cytokine known for its pleiotropic effects on various
types of cells and tissues. EPO and its receptor EPOR trigger signaling cascades …

Protein tyrosine kinases: their roles and their targeting in leukemia

K K. Bhanumathy, A Balagopal, FS Vizeacoumar… - Cancers, 2021 - mdpi.com
Simple Summary Protein phosphorylation is a key regulatory mechanism that controls a
wide variety of cellular responses. This process is catalysed by the members of the protein …

HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy

M Chen, MC Menon, W Wang, J Fu, Z Yi, Z Sun… - Nature …, 2023 - nature.com
Renal inflammation and fibrosis are the common pathways leading to progressive chronic
kidney disease (CKD). We previously identified hematopoietic cell kinase (HCK) as …

Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK

K Dhami, A Chakraborty, TL Gururaja, LWK Cheung… - Science …, 2022 - science.org
The Bruton's tyrosine kinase (BTK) inhibitor ibrutinib irreversibly binds BTK at Cys481,
inhibiting its kinase activity and thus blocking transduction of B cell receptor (BCR) signaling …

Mutational analysis of structural proteins of SARS-CoV-2

S Jakhmola, O Indari, D Kashyap, N Varshney, A Das… - Heliyon, 2021 - cell.com
SARS-CoV-2 transmissibility is higher than that of other human coronaviruses; therefore, it
poses a threat to the populated communities. We investigated mutations among envelope …

CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity

JC Gutjahr, E Bayer, X Yu, JM Laufer… - …, 2020 - pmc.ncbi.nlm.nih.gov
Adhesive properties of leukemia cells shape the degree of organ infiltration and the extent of
leukocytosis. CD44 and the integrin VLA-4, a CD49d/CD29 heterodimer, are important …

[HTML][HTML] Insights on hematopoietic cell kinase: An oncogenic player in human cancer

S Luo, S Du, M Tao, J Cao, P Cheng - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Hematopoietic cell kinase (Hck) is a member of the Src family and is expressed in
hematopoietic cells. By regulating multiple signaling pathways, HCK can interact with …

Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK

V Kanderova, T Svobodova, S Borna, M Fejtkova… - Journal of Allergy and …, 2022 - Elsevier
Background Inborn errors of immunity are genetic disorders characterized by various
degrees of immune dysregulation that can manifest as immune deficiency, autoimmunity, or …

Identification of Pyrrolo[2,3-d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute …

X Yuan, Y Chen, W Zhang, J He, L Lei… - Journal of Medicinal …, 2019 - ACS Publications
A series of pyrrolo [2, 3-d] pyrimidine derivatives were prepared and optimized for cytotoxic
activities against FLT3-ITD mutant cancer cells. Among them, compound 9u possessed …

Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3

H Lu, X Weng, Y Sheng, J Wu, H Xi, X Cai - BMC cancer, 2022 - Springer
Background Midostaurin combined with chemotherapy is currently used to treat newly
diagnosed acute myeloid leukemia (AML) patients with FMS-like tyrosine kinase 3 (FLT3) …